Primary Record
ACRIVASTINE
- In stock
- 4,831 g
- Purity
- 99.6 %
- CAS
- 87848-99-5
Compound Identifiers & Properties
- CAS
- 87848-99-5
- PubChem CID
- 5284514
- SMILES
- CC1=CC=C(C=C1)/C(=C\CN2CCCC2)/C3=CC=CC(=N3)/C=C/C(=O)O
- Canonical SMILES
- Cc1ccc(/C(=C\CN2CCCC2)c2cccc(/C=C/C(=O)O)n2)cc1
Names & Synonyms
- ACRIVASTINE
- Semprex
- Acrivastina
- Acrivastinum
- Acrivastin
- 87848-99-5
- Semprex-D
- Acrivastinum [Latin]
- Acrivastina [Spanish]
- Mixture Name
- BW-825C
- BW 825C
- BW A825C
- Benadryl allergy relief
- A20F9XAI7W
- Acrivastine (Standard)
- Acrivastine [USAN:INN:BAN]
- Acrivastine Impurity 1
- Acrivastine (USAN/INN)
- UNII-A20F9XAI7W
- AC1NR4LM
- ACRIVASTINE [MI]
- RefChem:552703
- ACRIVASTINE [INN]
- BW825C
- ACRIVASTINE [USAN]
- DTXSID6022555
- MFCD00869830
- CHEBI:83168
- D0O4EU
- ACRIVASTINE [VANDF]
- AC1Q5T9P
- SCHEMBL4702
- DTXCID702555
- ACRIVASTINE [MART.]
- C22H24N2O2
- CHEMBL1224
- ACRIVASTINE [WHO-DD]
- MLS006010115
- BIDD:GT0209
- Acrivastine [USAN:BAN:INN]
- BW270C
- orb1302765
- orb3025951
- SCHEMBL29414102
- Acrivastine, >=98% (HPLC)
- HY-B1510R
- ACRIVASTINE [ORANGE BOOK]
- Benadryl Allgy Relief Plus Decongest
- BW-270C
- E-(9CI)
- R06AX18
- PWACSDKDOHSSQD-IUTFFREVSA-N
- GLXC-06069
- HMS3886E20
- HMS5085G17
- BCP06189
- BW 0270C
- HY-B1510
- MSK10897
- ZINC3776633
- Tox21_113015
- AC-912
- BDBM50487466
- EBC-26685
- KM2560
- NCGC00182053-02
- s5718
- AKOS005067182
- C22-H24-N2-O2
- SEMPREX-D COMPONENT ACRIVASTINE
- CID5284514
- CS-6454
- CS-O-00802
- DB09488
- FA31634
- CID:5284514
- NCGC00182053-03
- AN-15417
- AS-14623
- BC224208
- J22.097C
- L917
- SID:92729786
- SMR004701250
- SY053288
- (E)-6-((E)-3-(1-Pyrrolidinyl)-1-p-tolylpropenyl)-2-pyridineacrylic acid
- CAS-87848-99-5
- LS-178016
- 2-Propenoic acid, 3-(6-(1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)-2-pyridinyl)-, (E,E)-
- FT-0686409
- NS00003303
- (E)-3-(6-((E)-3-(Pyrrolidin-1-yl)-1-(p-tolyl)prop-1-en-1-yl)pyridin-2-yl)acrylic acid
- D02760
- D70156
- SBI-0654147.0001
- 2-Propenoic acid,3-[6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl]-2-pyridinyl]-,(2E)-
- 54338-EP2308562A2
- EN300-7363287
- (E)-3-[6-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridin-2-yl]prop-2-enoic acid
- (E)-6-((E)-3-(1-Pyrrolidinyl-1-p-tolylpropenyl)-2-pyridinacrylsaeure
- 848A995
- A916142
- C043648
- Q342745
- SR-01000942220
- I14-8671
- SR-01000942220-1
- BRD-K50163129-001-01-4
- (2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}prop-2-enoic acid
- (E)-3-[6-[(E)-1-(p-tolyl)-3-pyrrolidin-1-yl-prop-1-enyl]-2-pyridyl]prop-2-enoic acid
- 3-{6-[1-(4-methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}prop-2-enoic acid
- (2E)-3-[6-[(1E)-1-(4-Methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl]-2-propenoic acid
- (2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic acid
- (2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-en-1-yl]pyridin-2-yl}prop-2-enoic acid
- (E)-3-{6-[3-pyrrolidino-1-(4-tolyl)prop-1E-enyl]-2-pyridyl}acrylic acid
- (E)-6-[(E)-3-(1-pyrrolidinyl)-1-p-tolylpropenyl]-2-pyridineacrylic acid
- 6-(3-(1-PYRROLIDINYL)-1-P-TOLYLPROPENYL)-2-PYRIDINEACRYLIC ACID
- (E)-6-[(E)-3-(Pyrrolidin-1-yl)-1-(4-methylphenyl)-1-propenyl]-2-pyridinepropenoic acid
- 3-(6-(1-(4-METHYLPHENYL)-3-(1-PYRROLIDINYL)-1-PROPENYL)-2-PYRIDINYL)-
- ( E,E )-3-[6-[1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl]-2-pyridinyl]-2-propenoic acid
- (2E)-3-(6-((1E)-1-(4-methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl)pyridin-2-yl)acrylic acid
- (2E)-3-(6-((1E)-1-(4-methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl)pyridin-2-yl)prop-2-enoic acid
- (2E)-3-{6-[(1E)-1-(4-Methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl}acrylic acid
- (E)-3-[6-[(E)-1-(4-Methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl]-2-pyridinyl]propenoic acid
- (E)-3-[6-[(E)-1-(4-Methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl]-2-pyridyl]propenoic acid
- (E,E)-3-[6-[1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl]-2-pyridinyl]-2-propenoic acid
- 2-Propenoic Acid, 3-(6-(1-(4-Methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)-2-pyridinyl)-,(E,E)-
- 2-Propenoic acid, 3-[6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl]-, (2E)-; 2-Propenoic acid, 3-[6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl]-2-pyridinyl]-, (2E)- (9CI); 2-Propenoic acid, 3-[6-[1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl]-2-pyridinyl]-, (E,E)-; Acrivastine; BW 0270C; BW 825C; BW A825C; Semprex; Acrivastine